Welcome to our dedicated page for BlackRock ESG Capital Allocation Term SEC filings (Ticker: ECAT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT) brings together the fund’s regulatory disclosures as a non-diversified, closed-end management investment company. As a registered investment company, ECAT files documents with the U.S. Securities and Exchange Commission that describe its structure, investment objectives, governance, and material corporate actions.
Regulatory materials referenced in public announcements include tender offer statements on Schedule TO, proxy statements for annual meetings, and related exhibits. Tender offer documents outline the terms under which ECAT has offered to repurchase a portion of its outstanding common shares, including the percentage of shares subject to the offer and the method for determining the purchase price as a percentage of net asset value on a specified date.
Proxy statements and associated filings provide details on proposals submitted to shareholders, such as the election of trustees and a shareholder proposal to terminate BlackRock Advisors, LLC as investment adviser. These filings also form the basis for recommendations issued by proxy advisory firms Institutional Shareholder Services, Glass Lewis, and Egan-Jones, which are discussed in Business Wire releases.
Litigation involving ECAT’s voting bylaws, brought by Saba Capital Management, L.P., is also connected to the fund’s regulatory framework under the Investment Company Act. Court rulings described in public news highlight questions about how ECAT’s voting standards interact with statutory requirements for shareholder elections and board composition.
On Stock Titan, ECAT’s SEC filings are supplemented with AI-powered summaries that explain the key points of lengthy documents in plain language. Real-time updates from the SEC’s EDGAR system allow users to see new filings as they appear, while AI-generated highlights help identify important items in tender offer statements, proxy materials, and other disclosures. This structure enables investors to review ECAT’s regulatory history, advisory arrangements, and governance-related filings more efficiently.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported two open‑market sales of common stock. On February 5, 2026, it sold 131,090 shares at $15.11 per share. On February 6, 2026, it sold an additional 36,044 shares at $15.29 per share.
After these transactions, Saba Capital Management, L.P. beneficially owned 24,506,184 ECAT common shares, held indirectly. The filing reflects portfolio activity by a large shareholder rather than any change in the issuer’s business operations.
Saba Capital Management and affiliates report a significant ownership position in BlackRock ESG Capital Allocation Term Trust. They disclose beneficial ownership of 24,673,318 common shares, representing 24.84% of the fund’s outstanding shares, based on 99,345,793 shares outstanding as of June 30, 2025.
The filing, Amendment No. 27 to a Schedule 13D, is jointly made by Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein. All reported shares are held with shared voting and dispositive power through funds and accounts advised by Saba Capital.
Saba states that approximately $366,779,210 was paid to acquire these shares, using investor subscription proceeds, capital appreciation and margin borrowings in the ordinary course, with all recent trades executed in the open market. The amendment specifically updates information on funding, ownership details and the transaction schedule.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust, reported two sales of ECAT common stock. On February 3, 2026, it sold 143,707 shares at $15.38 per share, leaving 24,824,510 shares indirectly beneficially owned. On February 4, 2026, it sold another 151,192 shares at $15.28 per share, leaving 24,673,318 shares indirectly beneficially owned.
BlackRock ESG Capital Allocation Term Trust portfolio manager Sarah Croughan Thompson reported a routine equity award vesting and sale. On January 30, 2026, 642.3734 phantom shares were converted into the same number of common shares at $0.00 per share and then 642.3734 common shares were sold at $15.44 per share, leaving her with no directly held common stock.
The filing shows she continues to hold 1,284.7468 phantom shares, which are the economic equivalent of common stock but are payable in cash, subject to vesting conditions that occur in three equal annual installments from the original January 31, 2025 grant.
BlackRock ESG Capital Allocation Term Trust (ECAT) portfolio manager Randy William Berkowitz reported a small insider transaction involving common stock and phantom shares. On January 30, 2026, he converted 659.337 phantom shares into 659.337 shares of common stock at an exercise price of $0.00 per share.
That same day, he disposed of 659.337 common shares at a price of $15.44 per share, leaving him with 0.0000 common shares directly owned. After the transaction, he continued to hold 1,318.6741 phantom shares, which are cash-settled instruments economically equivalent to common stock and payable in cash upon vesting.
BlackRock ESG Capital Allocation Term Trust (ECAT) portfolio manager Russell Jared Koesterich reported a Form 4 transaction on January 30, 2026. He acquired 5,134.5632 shares of common stock through the exercise of phantom share awards at $0.00 per share, then disposed of the same 5,134.5632 shares at $15.44 per share, leaving him with 0 common shares directly owned.
The filing also shows activity in cash-settled phantom shares, which are the economic equivalent of common stock and become payable in cash after vesting. One block of 3,160.7265 phantom shares relates to a January 31, 2025 grant that vests in three equal annual installments, with 6,321.453 phantom shares remaining. A second block of 1,973.8367 phantom shares comes from a January 31, 2024 grant with similar three-year vesting, all held as direct beneficial ownership.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a sale of common shares. On February 2, 2026, it sold 178,239 common shares at $15.55 per share in an open-market transaction coded as a sale.
After this transaction, Saba Capital Management, L.P. beneficially owned 24,968,217 ECAT common shares, held indirectly. The filing reflects an adjustment to an existing large position rather than an initial purchase or complete exit.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust, reported selling common stock in two January transactions.
It sold 166,027 shares at $15.44 on January 29 and 157,827 shares at $15.46 on January 30. After these indirect sales, it still beneficially owned 25,146,456 common shares.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported selling common shares in two transactions. On January 27, 2026, it sold 83,984 shares at $15.54 per share. On January 28, 2026, it sold a further 105,896 shares at $15.53 per share. After these sales, Saba Capital Management, L.P. reported 25,470,310 ECAT shares beneficially owned indirectly.
Saba Capital Management, L.P., a more than 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a routine share sale. On January 26, 2026, the firm sold 44,054 shares of ECAT common stock at a price of $15.54 per share, coded as a sale transaction.
After this trade, Saba Capital Management, L.P. reported indirect beneficial ownership of 25,660,190 ECAT common shares. The filing lists the ownership form as indirect, without specifying a particular intermediary entity in the ownership description.